Cargando…
Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial
BACKGROUND: Non-medical, non-pharmacological and pharmacological treatments are recommended for the prevention of migraine. The purpose of this randomized double-blind placebo controlled, multicenter trial was to evaluate the efficacy of a proprietary nutritional supplement containing a fixed combin...
Autores principales: | Gaul, Charly, Diener, Hans-Christoph, Danesch, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393401/ https://www.ncbi.nlm.nih.gov/pubmed/25916335 http://dx.doi.org/10.1186/s10194-015-0516-6 |
Ejemplares similares
-
Prophylactic effect of riboflavin on pediatric migraine: a randomized, double-blind, placebo-controlled trial
por: Talebian, Ahmad, et al.
Publicado: (2018) -
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
por: Goadsby, Peter J, et al.
Publicado: (2019) -
Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application
por: Diener, Hans-Christoph, et al.
Publicado: (2022) -
Aerobic endurance training versus relaxation training in patients with migraine (ARMIG): study protocol for a randomized controlled trial
por: Totzeck, Andreas, et al.
Publicado: (2012) -
Riboflavin prophylaxis in pediatric and adolescent migraine
por: Condò, Maria, et al.
Publicado: (2009)